Pharma

Your Article Summary

See Latest Articles

Amylin Pharmaceuticals Reports Third Quarter Financial Results
Amylin Pharmaceuticals, 10/21/09

Amylin Pharmaceuticals, Inc. reported financial results for the quarter ended September, 2009. The Company reported total revenue of $211.2 million for the third quarter, including net product sales of $192.9 million. Non–GAAP operating income was $0.6 million for the quarter ended September, 2009 compared to non–GAAP operating loss of $32.7 million for the same period in 2008. Net loss for the quarter ended September, 2009 was $26.7 million, or $0.19 per share compared to $79.0 million, or $0.58 per share for the same period in 2008. Net loss for the quarter ended September, 2008 included a loss on impairment of investments of $14.9 million, or $0.11 per share.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

HP to Acquire Networking Firm 3Com
HealthDataManagement, 11/20/09

Protox Reports 2009 Third Quarter Results
Protox Therapeutics , 11/18/09

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09

 See all of Financial Reports